No if it will not be a new active moiety and no if you will continue the same trademark to market. The interesting question is if you used a new trademark like a generic. I'm not sure if this is in the spirit of FDA's thinking for the coming soon regs, but I recall doing it I believe for the CFC-free version of QVAR (albuterol) metered does inhaler when I was general counsel of 3M Pharmaceuticals. Make sure you know how to do it correctly.
Mark DuVal, JD, FRAPS
DuVal & Associates, P.A.
Sent from my Verizon, Samsung Galaxy smartphone